Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease

Kidney International

Volumn 57, Issue 2, 2000, Pages 487-498

  Stokes, Michael B ^a,b   Holler, Susann ^a,b   Cui, Yan ^a,b   Hudkins, Kelly L ^a,b   Eitner, Frank ^a,b   Fogo, Agnes ^a,b   Alpers, Charles E ^a,b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amyloidosis; Arteriosclerosis; Extracellular matrix; Glomerulosclerosis; Growth factor; Mesangial sclerosis; Proteoglycans; Tubulointerstitial fibrosis

Indexed keywords

BIGLYCAN; COLLAGEN TYPE 1; DECORIN; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULONEPHRITIS; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY FIBROSIS; NEPHROSCLEROSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA ANALYSIS;

EID: 0033934431     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00868.x     Document Type: Article

References (37)

1. 1. IOZZO RV: Matrix proteoglycans: From molecular design to cellular function. Annu Rev Biochem 67:609-652, 1998
2. 2. KRESSE H, HAUSSER H, SCHONHERR E: Small proteoglycans. Experientia 49:403-416, 1993
3. 3. DAVIES M, KASTNER S, THOMAS GJ: Proteoglycans: Their possible role in renal fibrosis. Kidney Int 54(Suppl):S55-S60, 1996
4. 4. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCHI Y, PIERSCHBACHER MD, RUOSLAHTI E: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
5. 5. ISAKA Y, BREES DK, IKEGAYA K, KANEDA Y, IMAI E, NOBLE NA, BORDER WA: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 2:418-423, 1996
6. 6. BORDER WA, NOBLE NA: TGF-beta in kidney fibrosis: A target for gene therapy. Kidney Int 51:1388-1396, 1997
7. 7. SCHAEFER L, HAUSSER H, ALTENBURGER M, UGORCAKOVA J, AUGUST C, FISHER LW, SCHAEFER RM, KRESSE H: Decorin, biglycan and their endocytosis receptor in rat renal cortex. Kidney Int 54:1529-1541, 1998
8. 8. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis: Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453-462, 1990
9. 9. DIAMOND JR, LEVINSON M, KRFISBERG R, RICARDO SD: Increased expression of decorin in experimental hydronephrosis. Kidney Int 51:1133-1139, 1997
10. 10. BIANCO P, FISHER LW, YOUNG MF, TERMINE JD, ROBEY PG: Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 38:1549-1563, 1990
11. 11. NILMIR ZI, STEIN H, NORONHA IL, KRUGER C, ANDRASSY K, RITZ E, WALDHERR R: PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis. Kidney Int 48:1530-1541, 1995
12. 12. YOSHIOKA K, TAKEMURA T, MURAKAMI K, OKADA M, HINO S, MIYAMOTO H, MAKI S: Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 68:154-163, 1993
13. 13. DANIELSON KG, BARIBAULI H, HOLMES DF, GRAHAM H, KADLER KE, IOZZO RV: Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136:729-743, 1997
14. 14. SCHONHERR E, WITSCH-PREHM P, HARRACH B, ROBENEK H, RAUTERBERG J, KRESSE H: Interaction of biglycan with type I collagen. J Biol Chem 270:2776-2783, 1995
15. 15. RIESSEN R, ISNER JM, BLESSING E, LOUSHIN C, NIKOL S, WIGHT TN: Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 144:962-974, 1994
16. 16. STOKES MB, ALPERS CE: Combined membranous nephropathy and IgA nephropathy. Am J Kidney Dis 32:649-656, 1998
17. 17. FOGO A, QURFSHI N, HORN RG: Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis 22:367-377, 1993
18. 18. ALPERS CE, BIAVA CG: Idiopathic lobular glomerulonephritis (nodular mesangial sclerosis): A distinct diagnostic entity. Clin Nephrol 32:68-74, 1989
19. 19. FISHER LW, HAWKINS GR, TUROSS N, TERMINI JD: Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. J Biol Chem 262:9702-9708, 1987
20. 20. FLEISCHMAJLR R, MACDONALD ED, PERLISH JS, BURGESON RE, FISHER LW: Dermal collagen fibrils are hybrids of type I and type III collagen molecules. J Struct Biol 105:162-169, 1990
21. 21. FISHER LW, TERMINE JD, YOUNG MF: Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 264:4571-4576, 1989
22. 22. ALPERS CE, HUDKINS KL, FLOEGE J, JOHNSON RJ: Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 5:201-209, 1994
23. 23. LYON AW, NARINDRASORASAK S, YOUNG ID, ANASTASSIADES T, COUCHMAN JR, MCCARTHY KJ, KISILEVSKY R: Co-deposition of basement membrane components during the induction of murine splenic AA amyloid. Lab Invest 64:785-790, 1991
24. 24. SNOW AD, BRAMSON R, MAR H, WIGHT TN, KISILEVSKY R: A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J Histochem Cytochem 39:1321-1330, 1991
25. 25. WESTERMARK GT, NORLING B, WESTERMARK P: Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis. Clin Exp Immunol 86:150-156, 1991
26. 26. SNOW AD, MAR H, NOCHLIN D, KRESSE H, WIGHT TN: Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. J Histochem Cytochem 40:105-113, 1992
27. 27. MOSS J, SHORE I, WOODROW D: An ultrastructural study of the colocalization of biglycan and decorin with AA amyloid fibrils in human renal glomeruli. Amyloid 5:43-48, 1998
28. 28. WAHAB NA, HARPER K, MASON RM: Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia. Biochem J 316:985-992, 1996
29. 29. MOGYOROSI A, ZIYADEH FN: Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose. Am J Physiol 275:F827-F832, 1998
30. 30. WIGHT TN, LARA S, RIESSEN R, LE BARON R, ISNER J: Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries. Am J Pathol 151:963-973, 1997
31. 31. LIN H, WILSON JE, ROBERTS CR, HORLEY KJ, WINTERS GL, COSTANZO MR, MCMANUS BM: Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: Distinctness as compared to native atherosclerosis. J Heart Lung Transplant 15:1233-1247, 1996
32. 32. YAMAMOTO K, KUSACHI S, NINOMIYA Y, MURAKAMI M, DOI M, TAKEDA K, SHINJI T, HIGASHI T, KOIDE N, TSUJI T: Increase in the expression of biglycan mRNA expression co-localized closely with that of type I collagen mRNA in the infarct zone after experimentally-induced myocardial infarction in rats. J Mol Cell Cardiol 30:1749-1756, 1998
33. 33. HUNZELMANN N, ANDERS S, SOLLBERG S, SCHONHERR E, KRIEG T: Co-ordinate induction of collagen type I and biglycan expression in keloids. Br J Dermatol 135:394-399, 1996
34. 34. GREVE H, BLUMBERG P, SCHMIDT G, SCHLUMBERGER W, RAUTERBERG J, KRESSE H: Influence of collagen lattice on the metabolism of small proteoglycan II by cultured fibroblasts. Biochem J 269:149-155, 1990
35. 35. PYKE C, KRISTENSEN P, OSTERGAARD PB, OTURAI PS, ROMER J: Proteoglycan expression in the normal rat kidney. Nephron 77:461-470, 1997
36. 36. O'BRIEN KD, OLIN KL, ALPERS CE, CHIU W, FERGUSON M, HUDKINS K, WIGHT TN, CHAIT A: Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: Colocalization of biglycan with apolipoproteins. Circulation 98: 519-527, 1998
37. 37. EVANKO SP, RAINES EW, ROSS R, GOLD LI, WIGHT TN: Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am J Pathol 152:533-546, 1998